The Prevalence of Hepatitis C Virus Genotypes in Mazandaran Province, Iran

Ebrahimzadeh, Parisa; Haghshenas, Mohammadreza; Babamahmoodi, Farhang

doi:10.5812/jjm.40750

Cited by 3 publications

(3 citation statements)

References 33 publications

(37 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In the current study, HCV G1a was identified as the most abundant HCV genotype, which is the most prevalent worldwide and is the most frequently found in Northern Europe and North American (17). Previous reports showed that the most abundant HCV genotype was G1a (18), yet, in other studies conducted in Shiraz, Isfahan, and Mazandaran, G3a was the most common HCV genotype (19)(20)(21).…”

Section: Ast (Iu/l)mentioning

confidence: 54%

“…European studies show that G1a and G3a are relatively more common in young individuals. In some studies, G1b-infected patients were significantly older than those infected by other genotypes and a significant proportion of younger patients were infected with G3 (21). In some studies, it was determined that G1a and G1b were more common in people older than 50 years of age, whereas G1b was the most common subtype among people younger than 20 years old (36).…”

mentioning

confidence: 99%

See 1 more Smart Citation

Distribution of Hepatitis C Virus Genotypes in Rasht, Capital City of Guilan Province, Northern Part of Iran

Naghipour-Khalkhaliani

Behzadpour

Nasab

2018

Hepat Mon

View full text Add to dashboard Cite

Background: Hepatitis C infection is a major health problem around the world. It exhibits high genetic diversity, characterized by regional variations in genotype distribution. It seems that the hepatitis C virus genotypes are differently distributed between distinct geographical regions and also associated with different clinical outcomes and response to antiviral therapy. Objectives: The current study was performed to identify the distribution of HCV genotypes among chronic patients, who were HCV positive in Rasht, Capital City of Guilan Province, and Northern Part of Iran. Patients and Methods:The cross sectional study was carried out from June 2014 to February 2015. A total of 83 patients with anti-HCV-positive specimens were enrolled. Detection of HCV-RNA by Real Time-Polymerase Chain Reaction (RT-PCR) was performed from anti-HCV positive specimens, and HCV genotypes among plasma samples from RNA-HCV positive patients were then investigated using type-specific primers.

show abstract

Section: Ast (Iu/l)mentioning

confidence: 54%

mentioning

confidence: 99%

Distribution of Hepatitis C Virus Genotypes in Rasht, Capital City of Guilan Province, Northern Part of Iran

Naghipour-Khalkhaliani

Behzadpour

Nasab

2018

Hepat Mon

View full text Add to dashboard Cite

show abstract

“…Approximately 170-200 million (almost 3% of the world's population) people have been reported to have HCV infection worldwide. [ 3 4 ] The prevalence of HCV serotype in the general population of Iran has been reported as 0.5%-1%[ 5 ] and 6.7%[ 6 ] and 20%[ 7 ] in hemodialyzed and thalassemia patients, respectively. In 1989, HCV was identified as the most important cause of hepatitis following blood transfusion.…”

Section: Introductionmentioning

confidence: 99%

Identifying genotype profile of chronic hepatitis C infection in Southwest Iran

et al. 2020

View full text Add to dashboard Cite

Background: Hepatitis C virus (HCV) infection is one of the most important risk factors for liver failure which can lead to chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Approximately 170–200 million (almost 3% of the world's population) people have been reported to have HCV infection worldwide. HCV has six genotypes and multiple subtypes. HCV genotyping and identification of subtypes are critical steps for HCV vaccine development. Materials and Methods: In this community-based study, we aimed to investigate the HCV genotypes in infected patients referring to the laboratory of Hajar Hospital of Shahrekord city (the capital of Chaharmahal and Bakhtiari Province) in Iran from November 21, 2016, to October 21, 2017. During 2016–2017, the sera were obtained from 2377 individuals referring to the laboratory of Hajar Hospital of Shahrekord, Iran. The anti-HCV antibody was tested for all sera by enzyme-linked immunosorbent assay test. Following HCV RNA isolation and cDNA synthesis, HCV genotype detection was performed by quantitative reverse transcription-polymerase chain reaction. Results: Genotypes 3, 1a, and 1b were found in 28.6% (95% confidence interval [CI]: 17.0%–40.0%), 9.5% (95% CI: 2.1%–17.0%), and 3.2% (95% CI: 0.0%–7.6%) of the patients, respectively. In 5 patients (7.9%, 95% CI: 1.1%–14.8%), however, we did not observe any genotypes. We could not find any significant difference between the plasma viral load of infected patients and different genotypes. There was no significant difference either between age groups and genotypes ( P > 0.05). Conclusion: The findings of the present study determined that HCV genotype 3 was the predominant genotype followed by the genotypes 1a and 1b in Chaharmahal and Bakhtiari Province.

show abstract

Detecting and genotyping of HCV among hemodialysis patients in Diyala governorate

Khalaf¹,

Hussein²

2022

PROCEEDING OF THE 1ST INTERNATIONAL CONFERENCE ON ADVANCED RESEARCH IN PURE AND APPLIED SCIENCE (ICARPAS2021): Third Annual Con

View full text Add to dashboard Cite

The Prevalence of Hepatitis C Virus Genotypes in Mazandaran Province, Iran

Cited by 3 publications

References 33 publications

Distribution of Hepatitis C Virus Genotypes in Rasht, Capital City of Guilan Province, Northern Part of Iran

Distribution of Hepatitis C Virus Genotypes in Rasht, Capital City of Guilan Province, Northern Part of Iran

Identifying genotype profile of chronic hepatitis C infection in Southwest Iran

Detecting and genotyping of HCV among hemodialysis patients in Diyala governorate

Contact Info

Product

Resources

About